Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Research | January 9, 2025 |

Bringing Hope to People Living with Neurodegenerative Diseases

Alpha Cognition Inc. ( TSX-V.ACOG , OTCMKTS: ACOGF , Forum ) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases. Stockhouse Media’s Dave Jackson caught up recently with Company CE...
Dave Jackson | October 20, 2021 |

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William | May 15, 2020 |

Buzz on the Bullboards: No tariffs? No problem!

Following a significant drop on Monday, Canada’s main stock index, the TSX , rebounded on Tuesday. This recovery came after President Donald Trump temporarily backed down from his tariff threats against Ottawa, providing a month-long reprieve. The TSX&...
Jonathon Brown | February 6, 2025 |

Delivering innovative remote patient monitoring

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Cloud DX is emerging as the partner of choice among the largest global medical technology companies to provide innovative, best-in-class remote patient monitoring (RPM) solu...
Brieanna McCutcheon | September 22, 2022 |

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. Yesterday afternoon, Vi...
Streetwise Reports | December 7, 2019 |

Gold Above $1,600 As Iran Retaliates

We didn’t have to wait long for Iran’s response. After the missile attack on U.S. bases in Iraq, gold briefly soared above $1,600. What should we expect next? Iran Retaliates, Gold Rallies On Tuesday, I wrote that “given that Soleimani wa...
Arkadiusz Sieron | January 10, 2020 |

Here’s Why You Shouldn’t Panic Over China’s Factory Slowdown

Chinese manufacturing activity slumped to a record low in February as the coronavirus outbreak temporarily shuttered plants and factories and travel restrictions impacted the supply of labor. The official government purchasing manager’s index (PMI) fell to...
Frank Holmes | March 5, 2020 |

May 13th 2020, Crypto Chartbook: Transaction time and ability matters

Transaction time and ability matters One big aspect here at Midas Touch Consulting is wealth preservation. When the whole world writes article about the halving event we see no edge or urgency. Edges are not to be found when everybody is aware about them. Mutually you ca...
Korbinian Koller | May 15, 2020 |

Gold During Covid-19 Pandemic and Beyond

What a crazy six months! Let’s look at the chart below. As you can see, over the first half of the year, gold gained more than 16 percent , rising from $1,515 at the end of December 2019 to $1,762 at the end of June 2020. The beginning of the year...
Arkadiusz Sieron | July 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...